Team cbdMD Athlete Jessica-Rose Clark Wins Bantamweight Division in UFC Fight Night 178

CHARLOTTE, N.C., Sept. 23, 2020 /PRNewswire-PRWeb/ -- cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the "Company"), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, is proud to celebrate a night of triumph for Team cbdMD athlete and mixed martial arts expert, Jessica-Rose Clark, who won the women's bantamweight division match during UFC Fight Night 178. Airing this past Saturday night before a national audience from UFC Apex in Las Vegas, Clark took to the Octagon in dominant fashion - earning a resounding victory against Sarah Alpar during the Prelims Card. Clark overwhelmed Alpar and claimed the win via TKO stoppage during round three.

Though Clark was favored by oddsmakers, she certainly didn't look past her opponent. "This sport is the love of my life. So, you're going to see me fighting for my life out there," Clark said.

"The world really saw how complete of a fighter Jessy is with this fight, neutralizing takedowns and showing full standup domination. The bantamweight division is clearly where she belongs. She came into the fight mentally and physically in optimum shape, and we are honored to have her utilize and represent the cbdMD brand," said Hans Molenkamp, Vice President of Sports Marketing at cbdMD.

As for what's next for Clark, things are certainly moving quickly in her division. Odds are she will fight early next year, before proceeding to fight for the Bantamweight belt thereafter.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized cannabidiol (CBD) brands whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of "Team cbdMD." To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, Non THC1 CBD products, please visit, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to the expansion of the consumer market for CBD products and our ability to increase our market share, our limited operating history, our ability to expand our business and significantly increase our revenues, our ability to effectively leverage our brand partnerships and sponsorships, our ability to effectively compete in our market, our ability to achieve our net sales guidance, and our ability to report profitable operations in the future. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2019 as filed with the Securities and Exchange Commission (the "SEC") and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

1 Non-THC is defined as below the level of detection using validated scientific analytical tools



cbdMD, Inc.
Lauren Greene
Communications Specialist
(843) 743-9999


cbdMD, Inc.
John Weston
Director of Investor Relations
(704) 249-9515